Patterns of improvement following initial response in patients treated with naxitamab for relapsed/refractory high-risk neuroblastoma

被引：0
|
作者：
Mora, Jaume
Chan, Godfrey C.
Morgenstern, Daniel A.
Amoroso, Loredana
Nysom, Karsten
Faber, Joerg
Wingerter, Arthur
Bear, Melissa
Rubio-San-Simon, Alba
Tornoe, Karen
Duering, Maria
Kushner, Brian H.
机构：
[1] Hosp St Joan de Deu, Pediat Canc Ctr Barcelona, Barcelona, Spain
[2] Queen Mary Hosp, Hong Kong, Peoples R China
[3] Univ Hong Kong, Hong Kong Childrens Hosp, Pokfulam, Hong Kong, Peoples R China
[4] Hosp Sick Children, Toronto, ON, Canada
[5] IRCCS Ist Giannina Gaslini, Genoa, Italy
[6] Copenhagen Univ Hosp, Rigshosp, Copenhagen, Denmark
[7] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Pediat & Adolescent Med, Mainz, Germany
[8] Riley Hosp Children, Indianapolis, IN USA
[9] Hosp Infantil Univ Nino Jesus, Madrid, Spain
[10] Y mAbs AS, Horsholm, Denmark
[11] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
10033
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Outcome in patients with refractory high-risk neuroblastoma.
    Siddiqui, Amir Bari
    Oppong, Akosua
    Yuan, Cindy
    Gao, Guimin
    Bagatell, Rochelle
    Berg, Katherine
    Sokol, Elizabeth
    MacQuarrie, Kyle
    Pinto, Navin R.
    Gollapudi, Anurekha
    Mody, Rajen
    Wolfe, Ian
    Shusterman, Suzanne
    Foster, Jennifer
    Smith, Valeria
    Cohn, Susan Lerner
    Desai, Ami Vijay
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma
    Quintarelli, Concetta
    del Bufalo, Francesca
    Locatelli, Franco
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (24): : 2303 - 2304
  • [23] GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma
    Del Bufalo, Francesca
    De Angelis, Biagio
    Caruana, Ignazio
    Del Baldo, Giada
    De Ioris, Maria A.
    Serra, Annalisa
    Mastronuzzi, Angela
    Cefalo, Maria G.
    Pagliara, Daria
    Amicucci, Matteo
    Li Pira, Giuseppina
    Leone, Giovanna
    Bertaina, Valentina
    Sinibaldi, Matilde
    Di Cecca, Stefano
    Guercio, Marika
    Abbaszadeh, Zeinab
    Iaffaldano, Laura
    Gunetti, Monica
    Iacovelli, Stefano
    Bugianesi, Rossana
    Macchia, Stefania
    Algeri, Mattia
    Merli, Pietro
    Galaverna, Federica
    Abbas, Rachid
    Garganese, Maria C.
    Villani, Maria F.
    Colafati, Giovanna S.
    Bonetti, Federico
    Rabusin, Marco
    Perruccio, Katia
    Folsi, Veronica
    Quintarelli, Concetta
    Locatelli, Franco
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (14): : 1284 - 1295
  • [24] Patterns and Outcomes of Relapse Treated With Radiotherapy Following Total Marrow and Lymphoid Irradiation in High-Risk and/or Relapsed/Refractory Acute Leukemia
    Ladbury, C. J.
    Semwal, H.
    Hong, D.
    Yang, D.
    Marcucci, G.
    Nakamura, R.
    Al Malki, M.
    Rosenthal, J.
    Stein, A.
    Hui, S. K.
    Ali, H.
    Wong, J. Y. C.
    Dandapani, S. V.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S80 - S81
  • [25] The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial
    Mora, Jaume
    Chan, Godfrey C. F.
    Morgenstern, Daniel A.
    Amoroso, Loredana
    Nysom, Karsten
    Faber, Joerg
    Wingerter, Arthur
    Bear, Melissa K.
    Rubio-San-Simon, Alba
    de las Heras, Blanca Martinez
    Tornoe, Karen
    Duering, Maria
    Kushner, Brian H.
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [26] Naxitamab for the treatment of refractory/relapsed high-risk neuroblastoma (HR NB): Updated efficacy and safety data from the international, multicenter phase II trial 201
    Mora, J.
    Bear, M.
    Chan, G.
    Morgenstern, D. A.
    Nysom, K.
    Tornoe, K.
    Losic, N.
    Kushner, B.
    ANNALS OF ONCOLOGY, 2021, 32 : S833 - S833
  • [27] Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation
    Li, Richard
    Polishchuk, Alexei
    DuBois, Steven
    Hawkins, Randall
    Lee, Stephanie W.
    Bagatell, Rochelle
    Shusterman, Suzanne
    Hill-Kayser, Christine
    Al-Sayegh, Hasan
    Diller, Lisa
    Haas-Kogan, Daphne A.
    Matthay, Katherine K.
    London, Wendy B.
    Marcus, Karen J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (02): : 270 - 277
  • [28] Allogeneic transplantation for patients with high-risk or refractory neuroblastoma.
    Driscoll, T. A.
    Martin, P. L.
    Moffet, J.
    Daniel, M.
    Page, K.
    Parikh, S.
    Prasad, V.
    Szabolcs, P.
    Kurtzberg, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [29] Progression-free survival of two cases of high-risk neuroblastoma with refractory/relapsed disease following surgery alone
    Sokol, Elizabeth
    Haut, Paul R.
    Gosiengfiao, Yasmin
    Feinstein, Kate
    Pytel, Peter
    Cohn, Susan L.
    PEDIATRIC BLOOD & CANCER, 2013, 60 (03) : 512 - 514
  • [30] Prognosis of Patients with Relapsed, High-risk Neuroblastoma: A Single Center Experience
    Yamada, Yuji
    Kiyotani, Chikako
    Shioda, Yoko
    Osumi, Tomoo
    Kato, Motohiro
    Tomizawa, Daisuke
    Terashima, Keita
    Hishiki, Tomoro
    Fujino, Akihiro
    Kanamori, Yutaka
    Fuji, Hiroshi
    Yoshioka, Takako
    Miyazaki, Osamu
    Matsumoto, Kimikazu
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S41 - S42
12345